BioSpace News Archive

Transparency Market Research has published a new report titled, ‘Medical Cameras & Microscopes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The global industrial microbiology market is growing, thanks to the rising preference for industrial automation across the globe.

According to the report, the global hemoglobin feed market was valued at US$ 216.9 Mn in 2019 and is projected to expand at a CAGR of 4% from 2020 to 2030.

Demands for antibodies have risen strikingly for a range of research and diagnostic applications. Particularly, the demand for custom antibodies for drug development and diagnostics has grown steadily over the past few decades.

According to the report, the global depth of anesthesia monitoring devices market was valued at ~US$ 256 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Acura Pharmaceuticals, Inc. announced the successful completion of three NDA required registration batches of the to-be-marketed LTX-03 formulation.

BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced its Phoenix, Arizona location has earned Specialty Pharmacy Accreditation from URAC, the leading independent accrediting organization focused on supporting the quality of health care through leadership, accreditation, measurement and innovation standards and programs.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced it has initiated a sheep study to investigate MN-166 in an ovine model of chlorine-induced acute lung injury.

Spinogenix, Inc. a pharmaceutical company focused on the development of novel synaptogenic small molecule therapies for central nervous system disorders and rare diseases, announced it has been granted Orphan Drug Designation for SPG302 in amyotrophic lateral sclerosis by the U.S. Food and Drug Administration.